Anthera Pharmaceuticals Inc (ANTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,172 | -7,916 | -30,861 | -21,664 | -15,861 |
| Depreciation Amortization | 260 | 131 | 1,522 | 1,389 | 1,255 |
| Accounts payable and accrued liabilities | -519 | 1,806 | -1,833 | -3,661 | -3,465 |
| Other Working Capital | 435 | 1,675 | -5,730 | -8,404 | -7,161 |
| Other Operating Activity | 1,811 | -970 | 4,990 | 6,125 | 5,437 |
| Operating Cash Flow | $-13,185 | $-5,274 | $-31,912 | $-26,215 | $-19,795 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 5,328 | 4,831 | 4,172 |
| PPE Investments | N/A | N/A | -15 | -15 | N/A |
| Other Investing Activity | 8,100 | 2,400 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $8,100 | $2,400 | $-4,687 | $-5,184 | $-5,828 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 19,798 | 19,798 | 19,798 |
| Common Stock Issued | 9,564 | 3,117 | 45,785 | 45,454 | 44,737 |
| Other Financing Activity | -9,528 | -3,114 | -22,468 | -21,722 | -21,038 |
| Financing Cash Flow | $36 | $3 | $43,115 | $43,530 | $43,497 |
| Exchange Rate Effect | N/A | N/A | -1 | -1 | -1 |
| Beginning Cash Position | 25,946 | 25,946 | 19,431 | 19,431 | 19,431 |
| End Cash Position | 20,897 | 23,075 | 25,946 | 31,561 | 37,304 |
| Net Cash Flow | $-5,049 | $-2,871 | $6,515 | $12,130 | $17,873 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,185 | -5,274 | -31,912 | -26,215 | -19,795 |
| Capital Expenditure | 0 | 0 | -15 | -15 | N/A |
| Free Cash Flow | -13,185 | -5,274 | -31,927 | -26,230 | -19,795 |